ReviewEuropean journal of medical research2025
Exploring the role of circular RNAs in endometrial cancer progression and chemoresistance: Implications for targeted therapies.
Review in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Endometrial cancer stands as a prevalent malignant tumor of the female genital tract, while showing growing incidence statistics. Circular RNAs (circRNAs) demonstrate translational value as biomarkers and therapeutic targets in endometrial cancer because they affect chemoresistance and tumor progression through miRNA interactions, which makes them attractive candidates for non-invasive diagnostic tools and targeted medical approaches. Through their miRNA sponge activity, they regulate gene expression together with their ability to modulate RNA-binding proteins, affect mRNA stability and impact the PTEN/PI3K/Akt and MAPK pathways that enable tumor growth and survival. The study demonstrates how circRNAs function through multiple mechanisms in endometrial cancer development, yet indicates their value as therapeutic targets for disease management. The paper explores how recent developments utilize circRNA strategies to combat chemoresistance alongside improving targeted therapy research. Future research must focus on optimizing detection methods while developing standardized diagnostic procedures and performing large-scale validation studies to establish clinical utility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.